Rob van Wijk
Rob van Wijk (M.Sc.) is PhD student at the Division of Pharmacology.
Rob van Wijk studied Bio-Pharmaceutical Sciences at Leiden University. After two BSc internships, at the LACDR divisions of Toxicology and Pharmacology, he decided to specialize in Pharmacology during his MSc, with a specific focus on preclinical pharmacological research and its translational potential.
His first MSc internship on Candidate selection in tuberculosis drug development was at GlaxoSmithKline in London, where he learned to appreciate translational pharmacology from an industrial perspective. Rob came back to the LACDR for his second internship on Dopamine D2 receptor occupancy by antipsychotics at the Division of Pharmacology, with emphasis on the complete preclinical pharmacological workflow; from experimental data to modelling and simulation.
In September 2016 he started his PhD on Systems Pharmacology based translational drug pharmacokinetics; a multi-disciplinary project with collaborators from three different departments of two research institutes of Leiden University.